TOP

Products
Products

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

How Is AI Being Used to Enhance Traditional Life Underwriting?
We discuss how life underwriting decisions predicted by an AI model can work with the traditional underwriting process, and how to balance efficiency and accuracy. We describe the benefits that life underwriting with AI can bring to insurers, as well as some of the challenges.
Dr. (Celia) Ying Zhang
Generative Artificial Intelligence and Its Implications for Weather and Climate Risk Management in Insurance
Gen AI is changing how insurers manage weather and climate risks. It delivers faster, cheaper, and more accurate forecasts. With smart integration, insurers can improve underwriting, claims, and capital planning. This blog includes three approaches to forecasting.
Frank Schmid
GLP-1 Receptor Agonists – From Evolution to Revolution
GLP-1 receptor agonists, such as Ozempic and Tirzepatide, are FDA-approved for a growing list of conditions, including diabetes, obesity, cardiovascular risk reduction, sleep apnea, and more. This article provides an overview of the drugs.
Dr. Jonah Fox
The Potential of AI for Process Innovation
New technologies demand new approaches. This is true with the emergence of a general-purpose technology (GPT) such as generative artificial intelligence (Gen AI). What defines a GPT, and what are the implications of Gen AI in process innovation? A look at decision-making in Gen AI-driven innovation.
Frank Schmid
Das Potenzial von KI für Prozessinnovation
Neue Technologien erfordern neue Ansätze. Dies gilt insbesondere für das Aufkommen einer Basistechnologie wie der generativen künstlichen Intelligenz (Gen AI). Was definiert eine Basistechnologie und welche Auswirkungen hat Gen AI auf die Prozessinnovation?
Frank Schmid

Find an Expert in Your Region